Recently mutations in sphingosine-1-phosphate lyase (SGPL1) have been linked to adrenal insufficiency with treatment resistant nephrotic syndrome, dubbed sphingosine phosphate lyase insufficiency syndrome (SPLIS) [11,42]. Here, SGPL1 is linked to nephrotic syndrome.